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provided. Using the internal reporting template, the number of
process-related measures will be presented. For outcome-related
measures, the global metric reporting approach will be described
and a reporting template will be shared. An example of a project-
speciﬁc reporting template will be presented.
Lessons Learned: To date, we have learnt that the key steps
to establishing a new CDP include early involvement of key
clinical expert stakeholders in guideline development, the
need to minimize the burden of these clinical experts, and
involvement of senior leadership as needed to ensure that
progress continues to be made. In addition, collaboration is
important to minimize duplication of effort and to increase the
efﬁciency of the CDP. Finally, developing a plan a priori for
guideline dissemination, implementation, and assessment is
needed.
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THE USE OF AN EVIDENCE-BASED PRACTICE STRATEGY
TO IMPROVE QUALITY INTHE ACUTE CARE
SETTING
Mutnick AH,Wong PK, Hanseman DJ
Mercy Health Partners, Southwest Ohio, Cincinnati, OH, USA
Organization: Mercy Health Partners, Southwest Ohio. The
regional ofﬁce consists of 5 acute care hospitals and 6 Long Term
Care Nursing Homes with over 8000 employees and 2000 phy-
sicians on staff.
Problem or Issue Addressed: The availability of a growing body
of high quality evidence-based practice guidelines has created
exceptional opportunities to maximize the quality of care deliv-
ered to patients. However, are we utilizing the available evidence
in daily practice, or are individual clinician preferences still dic-
tating practice levels? Can evidence-based practice recommenda-
tions be translated into a community-based health care system?
Goals: The provision of evidence-based practice attributes within
a series of designated order sets; The ability to maximize consis-
tency, reduce variability, and to evaluate the delivery of quality
patient care; The ability to build-in practitioner ﬂexibility for
those respective areas, not supported by evidence-based practice;
To utilize an available “evidence-based practice” database, which
is continuously updated, and which allows timely dissemination
of updates across numerous disease entities.
Outcomes items used in the decision: We utilized effectiveness
data as reported in the peer-reviewed literature along with cur-
rently available evidence-based classiﬁcation schemes. Addition-
ally, we utilized the commercially available database, Zynx.
Rates of order set implementation were captured through a
program which allowed us to evaluate the clinical and ﬁnancial
outcomes associated with the newly adopted order sets versus
alternative order sets used by clinicians.
Implementation Strategy: The initial step in our implementation
process occurred when our Healthcare Systems’ Board of Trust-
ees and Physicians Council agreed upon a goal to advance a
culture of quality through evidence based medicine and clinical
transformation during the early spring in 2006. After a series of
meetings held for the systems’ key clinical decision makers, an
initial group of order sets were identiﬁed for review, based on
high use, high costs, and key components of our Core Perfor-
mance Practice Measures. A group of 10 clinical order sets,
which included Community Acquired Pneumonia, Heart Failure,
Chest Pain, Caesarean Section Delivery, Pelvic Delivery, Special
Care Nursery, Newborn Nursery, Deep Vein Thrombosis Pro-
phylaxis, and Erythrocyte Stimulating Factors. Through the con-
sensus process, the clinical leadership adopted an evidence-based
algorithm for our health system, which was subsequently
approved by our Board of Trustees. The algorithm employs select
evidence classiﬁcation schemes currently available in the peer-
reviewed literature. The order sets were all adopted by the health
system. A ﬁnal step in the process was to develop an electronic
data capture instrument, which would allow us to quantify the
implementation rate for each of the order sets that were
approved.
Results: We will share the ﬁnancial and clinical outcomes, which
have been evaluated for our initial order sets as well as select
metrics, which demonstrate the level of acceptance within our
Health System.
Lessons Learned: The initial lesson learned early in our imple-
mentation process was that trying to standardize clinical practice
amongst a large group of physicians throughout a ﬁve-hospital
health care system will occur via an evolutionary process rather
then a revolutionary process. Additionally, we learned that the
development of order sets required two key components, 1) An
evidence-based component based on a high degree of literature-
based recommendations, and 2) A practice-based component,
which utilized clinician-practice experience, not in conﬂict with
evidence-based practice, for those areas not supported by
evidence-based recommendations.
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OBJECTIVE: This study used linked SEER-Medicare data to
analyze recent treatment patterns and trends among elderly CRC
patients in the US. METHODS: Study cohorts included patients
aged 65+ newly diagnosed with adenocarcinoma of the colon
(CC) or rectum (RC) between 1996 and 2002 (n = 60,916) and
1:1 age/sex/location-matched patients from a Medicare 5%
sample. Cohorts were followed from index until death or Decem-
ber 31, 2005 to evaluate differences in clinical characteristics,
resource use, and initial treatment modalities by cancer site and
stage. To analyze trends, a standardized 3-year follow-up was
used. RESULTS: Mean (SD) age among CRC patients and
controls was 77 (7) years, 46% were male, and 84% were
white. About 28% of patients had rectal cancer. Overall, 7% of
CRC patients were diagnosed at Stage 0, 24% at Stage 1, 28% at
Stage 2, 21% at Stage 3, and 15% at Stage 4 (remainder were
unstaged). Between 1996 and 2002, surgery was the primary
treatment among CC patients (range: 73–78%), followed by
combined surgery/chemotherapy (16–20%), with very little
radiation use (<2%). Among RC patients, surgery was the
primary treatment (range: 53–56%), followed by surgery/
chemoradiotherapy (15–17%), surgery/radiotherapy (8–11%),
surgery/chemotherapy (7–9%) and no treatment (7–11%). CRC
patients used signiﬁcantly (P < .001) more health care resources
than controls in every category, with the largest differences in use
of hospital (23 vs. 12 days), home health (47% vs. 30%) and
hospice (24% vs. 9%). Use of all resources remained steady from
1996 to 2002, with slight declines in use of home health (from
47% to 41%; P < .001) and skilled nursing (from a mean of 9 to
8 days; P = .017) and a slight increase in hospice use (from 16%
to 19%; P < .001). CONCLUSION: Treatment patterns and
resource use among CRC patients remained steady between 1996
and 2002, and resource use was substantial.
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